F369-0055 Screening compound: 3-(4-fluorophenyl)-4-[2-(2-methylpiperidin-1-yl)-2-oxoethyl]-1-sulfanylidene-1H,4H,5H-[1,3]thiazolo[3,4-a]quinazolin-5-one

F369-0055 Screening compound: 3-(4-fluorophenyl)-4-[2-(2-methylpiperidin-1-yl)-2-oxoethyl]-1-sulfanylidene-1H,4H,5H-[1,3]thiazolo[3,4-a]quinazolin-5-one
F369-0055 Screening compound: 3-(4-fluorophenyl)-4-[2-(2-methylpiperidin-1-yl)-2-oxoethyl]-1-sulfanylidene-1H,4H,5H-[1,3]thiazolo[3,4-a]quinazolin-5-one alternative view

Chemical Structure Depiction of ChemDiv screening compound F369-0055
3-(4-fluorophenyl)-4-[2-(2-methylpiperidin-1-yl)-2-oxoethyl]-1-sulfanylidene-1H,4H,5H-[1,3]thiazolo[3,4-a]quinazolin-5-one

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F369-0055

Molecular Formula

C24H22FN3O2S2 (C24 H22 FN3 O2 S2)

Compound Name

3-(4-fluorophenyl)-4-[2-(2-methylpiperidin-1-yl)-2-oxoethyl]-1-sulfanylidene-1H,4H,5H-[1,3]thiazolo[3,4-a]quinazolin-5-one

IUPAC name

3-(4-fluorophenyl)-4-[2-(2-methylpiperidin-1-yl)-2-oxoethyl]-1-sulfanylidene-1H4H5H-[13]thiazolo[34-a]quinazolin-5-one

SMILES

CC(CCCC1)N1C(CN(C(N1c2c3cccc2)=C(c(cc2)ccc2F)SC1=S)C3=O)=O

InChI

InChI=1S/C24H22FN3O2S2/c1-15-6-4-5-13-26(15)20(29)14-27-22-21(16-9-11-17(25)12-10-16)32-24(31)28(22)19-8-3-2-7-18(19)23(27)30/h2-3,7-12,15H,4-6,13-14H2,1H3/t15-/m0/s1

InChI Key

UYOLFGXOAICTKO-HNNXBMFYSA-N

MDL Number (MFCD)

MFCD14952039

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

467.59

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

4.00

Number of Nitrogen and Oxygen Atoms

5

Partition Coefficient, logP

4.318

Distribution Coefficient, logD

4.318

Water Solubility, LogSw

-4.31

Polar Surface Area

33.465

Acid Dissociation Constant (pKa)

26.26

Base Dissociation Constant (pKb)

5.05

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

29.20

F369-0055 in Drug Discovery

Included in Screening Libraries

Eccentric PPI Library (11937 compounds)

Protein-Protein Interaction Library (218420 compounds)

Adenosine Receptors Targeted Library (19896 compounds)

Included in 1.7M Stock Database

Mechanism of action:
  • PPI modulators
  • PPI modulators
  • Receptor's ligands
Structure:
  • Cyclic compounds
Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Nervous system
  • Eye
  • Cardiovascular
Targets:
  • GPCR

References: we are preparing a list of scientific research reports with F369-0055 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound F369-0055?
Check Price and Availability of F369-0055, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of F369-0055 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for F369-0055
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for F369-0055
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of F369-0055 available by request